Endovia Health Sciences (EDVA) EBITDA (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) EBITDA (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.70 Bn | 133.84 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | -815.00 Mn |
| 5 | Revolution Medicines | 44.30 Bn | 44.30 Bn | - | -505.13 Mn |
| 6 | BeOne Medicines | 40.39 Bn | 35.29 Bn | 1.53 Bn | 325.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.40 Bn | 32.09 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Royalty Pharma | 28.07 Bn | 27.24 Bn | - | 133.12 Mn |
| 9 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | -2.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.01 Mn |
| Mar 31, 2026 | -978,970.00 |
| Dec 31, 2025 | -976,411.00 |
| Sep 30, 2025 | -9.54 Mn |
| Jun 30, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.66 Mn |
| Dec 31, 2024 | -289,630.00 |
| Sep 30, 2024 | -2.67 Mn |
| Jun 30, 2024 | -3.69 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -3.29 Mn |
| Sep 30, 2023 | -4.32 Mn |
| Jun 30, 2023 | -4.22 Mn |
| Mar 31, 2023 | -3.45 Mn |
| Dec 31, 2022 | -4.77 Mn |
| Sep 30, 2022 | -5.11 Mn |
| Jun 30, 2022 | -5.83 Mn |
| Mar 31, 2022 | -5.68 Mn |
| Dec 31, 2021 | -6.15 Mn |
| Sep 30, 2021 | -12.07 Mn |